January 9, 2020
AB Science announces that FDA green-lights U.S. patient enrollment in masitinib Phase 3 study following IND clearance in metastatic castrate-resistant prostate cancer eligible to chemotherapy
AB Science SA (NYSE Euronext - FR0010557264 - AB) today announces that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New ...
January 9, 2020
Valneva Expands its Commercial Operations with the Opening of its French Commercial Office
Saint-Herblain (France), January 9, 2020 – Valneva SE (“Valneva” or “the Company”) today announced a further expansion of its global commercial infrastructure with the opening ...
January 9, 2020
Compugen Highlights Recent Accomplishments and Previews Upcoming Milestones
HOLON, Israel, Jan. 9, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today provided an update ...
January 9, 2020
Oncolytics Biotech® Announces Key Opinion Leader Call Conducted by ROTH Capital Partners to Discuss Multiple Myeloma
SAN DIEGO and CALGARY, Alberta, Jan. 9, 2020 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, ...
January 9, 2020
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook
RAMSEY, N.J. and BOCA RATON, Fla., Jan. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing ...
January 9, 2020
Infinity Pharmaceuticals to Present Corporate Overview at 38th Annual J.P. Morgan Global Healthcare Conference
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins, Chief Executive Officer and Chair of Infinity Pharmaceuticals, will provide a corporate overview at the ...
January 9, 2020
DarioHealth Strengthens Management Team With Appointment of Digital Health Veteran Rick Anderson as President and General Manager, North America
NEW YORK, Jan. 9, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today the ...
January 9, 2020
Infinity Pharmaceuticals Raises $20 Million Through an Innovative Non-Dilutive Asset-Backed Financing from BVF
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) ("Infinity") today announced a $20 million non-dilutive asset-backed financing with BVF Partners L.P. ("BVF"), Infinity’s largest shareholder. This investment by ...
January 9, 2020
Cellectar Biosciences to Host a CLR 131 Clinical Data Call with Its Phase 2 Lead Investigator on February 19, 2020
FLORHAM PARK, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
January 9, 2020
Immutep Expands Part C of TACTI-002 Due to Positive Data
SYDNEY, Australia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments ...
January 9, 2020
Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne
REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 9, 2020/PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix" or the "Company"), a specialty pharmaceutical company, today announced that its novel AMZEEQ™ (minocycline) topical ...
January 9, 2020
EDAP Issues Letter to Shareholders
LYON, France, January 9, 2020 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in Robotic Energy-based Therapies, today issued the following letter to ...
January 8, 2020
LifeSci Public Relations Becomes LifeSci Communications, Reflecting Agency’s Evolution
NEW YORK, Jan. 08, 2020 (GLOBE NEWSWIRE) -- LifeSci Public Relations LLC, a global communications and marketing agency, today announced it has rebranded to LifeSci ...
January 8, 2020
LifeSci Capital Announces Transition to Fully Independent, High-Conviction Research Coverage
NEW YORK, Jan. 08, 2020 (GLOBE NEWSWIRE) -- LifeSci Capital LLC, a research-driven investment bank focused on the life sciences, today announced its transition to ...
January 8, 2020
Inspire Medical Systems, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
January 8, 2020
Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference
DUBLIN, Jan. 7, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective ...
January 8, 2020
Basilea at the 38th Annual J. P. Morgan Healthcare Conference – significant progress in Cresemba commercialization and R&D portfolio in 2019
Basel, Switzerland, January 08, 2020 – Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that company management, including CEO David Veitch, will be participating in the 38th ...
January 8, 2020
Kodiak Sciences to Present at 38th Annual J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 8, 2020 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, ...
January 8, 2020
BioLineRx to Present at the 2020 Biotech Showcase
TEL AVIV, Israel, Jan. 8, 2020 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that management ...
January 8, 2020
Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development
HOLON, Israel, Jan. 8, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the appointment of ...
Page 61 of 182